Latest News for: 1236

Edit

DEEP STATE DECODES 04.01.25 EPISODE 1236

Bitchute 02 Apr 2025
Go to the source via the article link to view the video or click the video icon ....
Edit

CERo Therapeutics Holdings, Inc. Poised to Initiate Enrollment of Phase 1 Trial of CER-1236 in ...

Nasdaq Globe Newswire 27 Mar 2025
Company reports acceptance of an abstract at the 2025 American Society of Clinical Oncology (ASCO) conference; Continues to be on track to dose first patient in first half of 2025 ... .
Edit

CERo Therapeutics Holdings, Inc. Presents Encouraging Preclinical Data Demonstrating CER-1236

Hastings Tribune 13 Mar 2025
SOUTH SAN FRANSCISCO, Calif., March 13, 2025 (GLOBE ...
Edit

CERo Therapeutics Holdings, Inc. Presents Encouraging Preclinical Data Demonstrating CER-1236 May be Targeted to Ovarian ...

Nasdaq Globe Newswire 13 Mar 2025
CERO) (“CERo” or the “Company”) an innovative immunotherapy company seeking to advance the next ...
  • 1

Article Search

tools
×
×
×
×